CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.309

-10.3%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (449)	4/7/2003 7:29:20 PM
From: SemiBull	Read Replies (1) of 668

Curis/Skin Cancer Drug: Shares Recently Up 80% >CRIS Monday April 7, 2:50 pm ET CAMBRIDGE, Mass. (Dow Jones)--Curis Inc. identified a new small molecule drug candidate, CUR-61414, for the treatment of basal cell carcinoma, a skin cancer. In a press release Monday, the therapeutic drug development company said CUR- 61414 prevents the proliferation and selectively induces the death of the tumor cells, while not harming adjacent normal skin cells in two different models of basal cell carcinoma. Curis' findings were published in the current online issue of The Proceedings of the National Academy of Sciences. Shares of Curis traded recently at $1.50, up 67 cents, or 80.7%, on Nasdaq Nasdaq volume of 2.6 million shares. Average daily volume is 40,820 shares. Company Web site: curis.com -Stephen Lee; Dow Jones Newswires; 201-938-5400

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next